GGrantIndex
← Leaderboards

Felipe Fregni

Spaulding Rehabilitation Hospital

$7,783,615
Attributed
$7,783,615
Total exposure
8
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.2M · FY200725
$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,783,615 · 8

By mechanism

R01$6,356,304 · 2
R21$1,412,866 · 3
M01$14,445 · 3

Top collaborators

No co-investigators on record.

Most similar at Spaulding Rehabilitation Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Indexing

Research focus

IndexingPainMotor CortexResponseQuality Of LifeDesignRandomizedChronicAffectNeuroregulationBrainBaseAreaMotorOperative Surgical ProceduresChronic PainPhysiologic PulseRehabilitation TherapySomatosensory CortexReportingPain ManagementAnalgesicsSensoryCombined Modality Therapy

Grant awards (25)

Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain with Machine Learning to Predict Treatment Response$635,017
R01 · FY2025 · HD · contact PI
Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain with Machine Learning to Predict Treatment Response$587,188
R01 · FY2024 · HD · contact PI
Mechanisms of Open and Hidden Placebo in Stroke Recovery$267,627
R21 · FY2024 · NS · contact PI
Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain with Machine Learning to Predict Treatment Response$612,355
R01 · FY2023 · HD · contact PI
Optimized tDCS for fibromyalgia: targeting the endogenous pain control system$407,946
R01 · FY2023 · AT · contact PI
Mechanisms of Open and Hidden Placebo in Stroke Recovery$222,776
R21 · FY2023 · NS · contact PI
Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain with Machine Learning to Predict Treatment Response$612,144
R01 · FY2022 · HD · contact PI
Optimized tDCS for fibromyalgia: targeting the endogenous pain control system$414,906
R01 · FY2021 · AT · contact PI
Optimized tDCS for fibromyalgia: targeting the endogenous pain control system$424,412
R01 · FY2020 · AT · contact PI
Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and tDCS$308,138
R01 · FY2020 · HD · contact PI
Optimized tDCS for fibromyalgia: targeting the endogenous pain control system$428,583
R01 · FY2019 · AT · contact PI
Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and tDCS$308,138
R01 · FY2019 · HD · contact PI
Optimized tDCS for fibromyalgia: targeting the endogenous pain control system$243,478
R01 · FY2019 · AT · contact PI
Optimized tDCS for fibromyalgia: targeting the endogenous pain control system$384,535
R01 · FY2018 · AT · contact PI
Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and tDCS$308,138
R01 · FY2018 · HD · contact PI
Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and tDCS$338,951
R01 · FY2016 · HD · contact PI
Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and tDCS$342,375
R01 · FY2015 · HD · contact PI
Low frequency rTMS and fluoxetine for motor recovery after ischemic stroke$241,312
R21 · FY2015 · HD · contact PI
Low frequency rTMS and fluoxetine for motor recovery after ischemic stroke$206,250
R21 · FY2014 · HD · contact PI
Investigation and treatment of central nervous system dysfunction in chronic pelv$246,218
R21 · FY2010 · DK · contact PI
Investigation and treatment of central nervous system dysfunction in chronic pelv$223,383
R21 · FY2009 · DK · contact PI
Investigation and treatment of central nervous system dysfunction in chronic pelv$5,300
R21 · FY2009 · DK · contact PI
CLINICAL TRIAL: TMS FOR THE TREATMENT OF SEVERELY AFFECTED STROKE$13,156
M01 · FY2008 · RR · contact PI
EFFECT OF TMS ON ABDOMINAL PAIN IN PATIENTS WITH PANCREATIC CANCER$703
M01 · FY2008 · RR · contact PI
EFFECT OF TMS ON ABDOMINAL PAIN IN PATIENTS WITH PANCREATIC CANCER$586
M01 · FY2007 · RR · contact PI